Richelle Cassell
Nurse Practitioner · New York, NYNPI 1871165530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 648 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 46.5% of the total. Reporting peaked in 2022 at $2,789 and has fallen 89.8% since, to $285 in 2025. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 648 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Biohaven Pharmaceuticals, Inc.$1K
- Pfizer$1K
- Lundbeck LLC$606
- Upsher-smith Laboratories LLC$603
- Biohaven Pharmaceutical Holding Company Ltd.$469
- plus $1K from 9 others
What the payments were for
- Consulting fees$8008%
- Food & beverage$9,41792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 264 | $4,753 |
| Biohaven Pharmaceuticals, Inc. | 54 | $1,410 |
| Pfizer | 66 | $1,015 |
| Lundbeck LLC | 54 | $606 |
| Upsher-smith Laboratories LLC | 70 | $603 |
| Biohaven Pharmaceutical Holding Company Ltd. | 49 | $469 |
| Lilly USA, LLC | 27 | $387 |
| Teva Pharmaceuticals USA, Inc. | 27 | $328 |
| Currax Pharmaceuticals LLC | 17 | $258 |
| Amgen | 12 | $241 |
| Tonix Medicines, Inc. | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Impel Pharmaceuticals LLC | 1 | $18 |
| Impel Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,064
- UBRELVY$539
How this compares
$10,217 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sumatriptan Succinate | 20 | $1,629 |
| RizatriptanRizatriptan Benzoate | 26 | $803 |
| Cyclobenzaprine Hcl | 21 | $11 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in New York
- Patricia McGoldrickNew York$202K
- Jodi LogerfoNew York$48K
- Aileen FerrickNew York$26K
- Tsz Isabel WongNew York$25K
- Chris BustamanteNew York$22K
- Mayra PozoNew York$14K
- Janet JohnsonNew York$12K
- Rachel RankinNew York$10K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.